Origin Genomics is wholly committed to providing our clients with the most effective cannabinoid therapies to help bring balance, healing and relief to their lives.OG sits at the epicenter of the convergence of three revolutions; the social and legal acceptance of cannabis, the explosion of clinical…
Origin Genomics is wholly committed to providing our clients with the most effective cannabinoid therapies to help bring balance, healing and relief to their lives.
OG sits at the epicenter of the convergence of three revolutions; the social and legal acceptance of cannabis, the explosion of clinical studies of cannabis and the commercialization of genomic medicines.
As such, OG was modeled and created to operate as an exponential organization (ExO) in the emerging world of cannabinoid therapies. An ExO is defined as: “one whose impact or (output) is disproportionately large - at least 10x larger compared to its peers because of the use of new organizational techniques that leverage accelerating technologies”.
The entirety of Origin’s management team and advisory board have first hand knowledge of the healing properties of Cannabis Sativa. It is these accumulated experiences that push Origin to help propel the plant’s mountain of anecdotal evidence to verifiable clinical proof so that it can enter into the accepted public domain of medicine where it so rightly belongs.
Origin firmly agrees with the medical community’s thought leaders that modern medicine is evolving into the era of Pharmacogenomics. Pharmacogenomics is defined as; targeted and individualized therapies rooted in an individual’s genomics and DNA sequencing. As such, OG will, based upon an individual’s genomic make up, ailment(s), medical history and ongoing lab results, formulate specific cannabinoid medicines to either alleviate symptoms of and on occasion alleviate root causes of certain disease states. These advances will give the medical community a significant tool in its quest for preventative therapies as opposed to reactive treatments.
Team (1)
Sectors Origin Therapeutics serves:
Life Sciences
Health Care
Join Axial's Private M&A Platform
Origin Therapeutics connects with qualified M&A advisors through the Axial Platform.
Looking for Buyers?
Reach this investor and hundreds more on Axial. No cost to advisors.
